Capnia is a privately held company located in Palo Alto, California, focused on the development and commercialization of novel therapeutic and diagnostic products to address significant unmet healthcare needs.
The first commercial product targets allergies (Allergic Rhinitis). Products under development include a novel diagnostic medical device to detect carbon monoxide levels in the breath.
For information regarding
ongoing clinical studies, please
contact Capnia at firstname.lastname@example.org.